Continued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.

Early relapsing disease has again shown the limitations of immunotherapy in triple-negative breast cancer after a trial found ...

The conventional BMI cutoff for obesity may be better replaced with adiposity measures that accommodate changes in the body ...

A doctor's mistake behind the wheel can have lasting consequences, ruining a professional reputation and the right to ...

Acrochordons, or skin tags, which are common, benign skin growths that appear in the axilla and other areas where frequent ...

Seniors are increasingly targeted in ever-sophisticated online financial cybercrimes, but mental health clinicians can play a ...

"Exciting" advance could finally pave the way to an artificial ovary and significantly boost women's health research.

New expert guidance to help clinicians manage the treatment of patients with epilepsy during pregnancy has been released.

Growing evidence suggests that a guideline-directed, treat-to-target strategy in patients with gout not only controls the ...

A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many ...

In an experiment that pitted the wits of pediatric dermatologists against ChatGPT versions 3.5 and 4.0 to answer board ...

Children hospitalized with asthma appear to be good candidates for telehealth-based asthma control, a pilot study found.